key: cord-1009768-gm4fyws4
authors: Shi, Xuan; Zhu, Lina; Wang, Sheng; Zhu, Wanli; Li, Quanfu; Wei, Juan; Feng, Di; Liu, Meiyun; Chen, Yuanli; Sun, Xuejun; Lu, Hongtao; Lv, Xin
title: Magnesium Hydride Ameliorates Endotoxin-Induced Acute Respiratory Distress Syndrome by Inhibiting Inflammation, Oxidative Stress, and Cell Apoptosis
date: 2022-04-26
journal: Oxid Med Cell Longev
DOI: 10.1155/2022/5918954
sha: d39caa6c0f3c7de84951a50c989e4b060856ee2c
doc_id: 1009768
cord_uid: gm4fyws4

Acute respiratory distress syndrome (ARDS) causes uncontrolled pulmonary inflammation, resulting in high morbidity and mortality in severe cases. Given the antioxidative effect of molecular hydrogen, some recent studies suggest the potential use of molecular hydrogen as a biomedicine for the treatment of ARDS. In this study, we aimed to explore the protective effects of magnesium hydride (MgH(2)) on two types of ARDS models and its underlying mechanism in a lipopolysaccharide (LPS)-induced ARDS model of the A549 cell line. The results showed that LPS successfully induced oxidative stress, inflammatory reaction, apoptosis, and barrier breakdown in alveolar epithelial cells (AEC). MgH(2) can exert an anti-inflammatory effect by down-regulating the expressions of inflammatory cytokines (IL-1β, IL-6, and TNF-α). In addition, MgH(2) decreased oxidative stress by eliminating intracellular ROS, inhibited apoptosis by regulating the expressions of cytochrome c, Bax, and Bcl-2, and suppressed barrier breakdown by up-regulating the expression of ZO-1 and occludin. Mechanistically, the expressions of p-AKT, p-mTOR, p-P65, NLRP3, and cleaved-caspase-1 were decreased after MgH(2) treatment, indicating that AKT/mTOR and NF-κB/NLRP3/IL-1β pathways participated in the protective effects of MgH(2). Furthermore, the in vivo study also demonstrated that MgH(2)-treated mice had a better survival rate and weaker pathological damage. All these findings demonstrated that MgH(2) could exert an ARDS-protective effect by regulating the AKT/mTOR and NF-κB/NLRP3/IL-1β pathways to suppress LPS-induced inflammatory reaction, oxidative stress injury, apoptosis, and barrier breakdown, which may provide a potential strategy for the prevention and treatment of ARDS.

Acute respiratory distress syndrome (ARDS) is a harmful host response, which is caused by various conditions such as sepsis, severe trauma shock, pancreatitis, or inhalation of poisonous gases [1] . ARDS remains the leading cause of morbidity and mortality (about 40%) in septic patients [2, 3] . ARDS is characterized by disruption of the alveolar endothelial and epithelial barrier [4, 5] , which in turn leads to pulmonary alveolar and interstitial edema, impaired gas exchange, and hypoxemia [6] . What's more, enhanced inflammation and oxidative stress are the pathologic hallmarks of ARDS [7] . The mechanism of ARDS remains unclear due to multiple cell types in the lung tissue, including endothelial cells, fibroblasts, and macrophages. At present, no effective pharmacotherapy is available to improve the survival rate of ARDS patients. In addition, ARDS survivors often suffer irreversible physical impairments, which seriously affect their quality of life [8] . Although many pharmacological therapies such as glucocorticoids, surfactants, protease inhibitors, and anti-inflammatory, antithrombotic, and fibrinolytic treatments have been attempted, none of them has proven to be fully effective [9] [10] [11] . Therefore, it is necessary to seek more effective treatments for ARDS by clarifying the underlying molecular mechanism.

Hydrogen gas (H 2 ) is a novel antioxidant, which was first reported by as being able to alleviate oxidative stress by suppressing hydroxyl radicals (•OH) and peroxynitrite (ONOO-) [12] . Hydrogen has been reported to possess antioxidative, anti-inflammation, and antiapoptosis effects [13] and demonstrated as a novel therapy for different diseases such as cerebral, myocardial, hepatic, renal, and intestinal diseases [14] [15] [16] [17] [18] [19] [20] . Especially, hydrogen inhalation can alleviate hypertoxic lung injury in rats [21] and protect mice against cigarette-induced chronic obstructive pulmonary disease (COPD) [22] . Hydrogen has been reported to reduce the cytokine storm and oxidative stress reactions in mice [23, 24] .

All the animal models in the above studies were treated with hydrogen mainly through three ways: hydrogen-rich water, hydrogen-rich normal saline (NS), and H 2 . As the hydrogen concentration in tissues depends on the administration route [25] , the amount of H 2 in hydrogen-rich water is limited. In this study, we used the magnesium hydride (MgH 2 ), a promising hydrogen source with high hydrogenstorage capacity (7.6 wt%), to treat ARDS. MgH 2 can produce a desired quantity of H 2 following hydrolysis reaction at room temperature: MgH 2 +2H 2 O → Mg(OH) 2 +2H 2 . As the by-product is poison-free, it is possible to make use of MgH 2 for biological application in clinical practice [26] .

The aim of this study was to investigate the role of MgH 2 in the pathophysiology of oxidative stress-mediated inflammation and apoptosis in ARDS, and provide evidencebased clues for use of MgH 2 as a novel therapeutic target against ARDS.

Male specific-pathogen-free (SPF) C57B/L6 mice weighing 20-25 g (Shanghai Lex Experimental Animal Center, Shanghai, China) were raised in SPF conditions. Animal care and experiments were approved by Shanghai Pulmonary Hospital (Shanghai, China) and performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH publications NO.8023, revised 1978). We used two types of ARDS models to detect the effects of MgH 2 and Mg(OH) 2 in alleviating ARDS. Firstly, mice were treated with intraperitoneal (i.p.) injection of LPS. Mice were used to observe survival rates in these four groups (CON group, treated with saline only; LPS group, treated with lipopolysaccharide, 15 mg/kg, i.p.; LPS+MgH 2 group, treated with MgH 2 at a daily dose of 50 mg/kg for 3 consecutive days before LPS injection; LPS+Mg(OH) 2 group, treated with Mg(OH) 2 at a daily dose of 110 mg/kg for 3 consecutive days before LPS injection to keep the concentration of Mg 2+ ion consistent in different groups) and LPS (10 mg/kg, i.p.) was used for the other experiments. Secondly, mice were treated with LPS intratracheally (5 mg/kg, i.t.) using a MicroSprayer syringe assembly (MSA-250-M, Penn Century, USA) as previously described [27] under anesthesia with 0.75% intraper-itoneal pentobarbital (75 μg/g). MgH 2 and Mg(OH) 2 were treated as previously described. 500 ng/ml LPS stimulation was used to establish the ARDS model. To determine the optimal MgH 2 concentration, A549 cells were treated with 50 μM, 100 μM, 200 μM, 500 μM, 1000 μM, and 2000 μM MgH 2 (Kemike, Wuhan, China). Finally, 500 μM was chosen as the appropriate concentration for the subsequent experiments. 5 mM N-Acetyl-L-cysteine (NAC) was added into cells as a positive control.

Assay. A549 cells were seeded into a 96well plate at 5 × 10 3 cells/ml, with addition of 100 μl culture medium to each well. After 24-hour pre-incubation in a cell incubator, 10 μl various concentrations of MgH 2 were added to the plate, with 3 wells for each concentration. 10 μl CCK8 reagent (Dojindo, Japan) was subsequently added into each well for 2-hour incubation. The optical density (OD) value was detected at the wavelength of 450 nm in a microplate reader. The whole process was repeated for 3 times.

Quantitative PCR (RT-qPCR). Total RNA was extracted from A549 cells and the lung tissues using Trizol reagent (Invitrogen, CA, USA) according to the manufacturer's instruction. The RNA concentration and purity were determined by 260/280 nm absorbance. Complementary DNA (cDNA) was reversed by reverse transcription kits (Vazyme, China). SYBR Green PCR kits (Yeasen, China) were used for RT-qPCR. The primers are listed in Table S1 , and the primers for RT-qPCR were synthesized by Shanghai Sangon Biotech Co., Ltd (Shanghai, China). The expression levels of all genes were normalized with the level of β-actin in the same group.

2.5. Western Blot. Western blot analysis was performed as previously described [28] . Cells were collected and washed twice with phosphate-buffered saline (1 × PBS), and then lysed in cytoplasmic protein extraction reagent A supplemented with 1 mM PMSF. Lung tissues were collected 24 hours after LPS injection. The protein concentrations of all samples were determined using a BCA protein assay kit (Thermo Fisher Scientific, San Jose, CA, USA). Total protein was separated by 10% SDS-PAGE gel and then transferred to a polyvinylidene fluoride (PVDF) membrane (BioRad, Hercules, California, USA). The membrane was blocked with 5% non-fat dry milk in Tween 20/Tris-buffered saline (TBST) for 2 hours at room temperature and incubated with primary antibodies overnight at 4°C. 

Weight (W/D) Ratio Analysis. The severity of lung damage was scored based on the following histologic features, as has been described previously [27] . The W/D ratio was calculated by measuring the wet weights of the lung tissues after lung injury and the dry weights were measured 24 hours after placing the lung tissue in an 80°C oven at three time points until the weights remained unchanged, based on which pulmonary edema was evaluated.

2.10. Reactive Oxidative Stress Activity Assay. The levels of malondialdehyde (MDA), glutathione (GSH), and the activity of superoxide dismutase (SOD) in the mouse lung tissues were measured with the assay kits (Jiancheng Institute of Biotechnology, Nanjing, China) following the manufacturers' protocols.

2.11. TUNEL Staining of Lung Tissue. Apoptosis cells in the paraffin-embedded sections were stained by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) using a kit as previously described [29] , followed by counterstaining with 4′6-diamidino-2-phenylindole (DAPI) for the nuclei. The experiment was performed according to the manufacturer's instructions (BioVision). The staining was observed under a fluorescence microscope (Olympus Corporation, magnification). TUNEL-positive cells were defined as cells with green staining (wavelength, 488 nm).

All experiments were performed with independent three replicates. The experimental data were presented as the mean ± standard deviation (SD). Differences were analyzed by SPSS 17.0 statistical software with one-way ANOVA followed by Tukey's post hoc test. Differences were determined to be statistical significance if P < 0:05. Corresponding significances were indicated in the figures.

3.1. MgH 2 Attenuates LPS-Induced ARDS and Improves the Survival Rate. LPS delivered at a dose of 15 mg/kg, killed 100% of mice within 3 days. Compared with LPS group, the survival rate of endotoxic mice treated with MgH 2 (50 mg/kg) was significantly improved to almost 40% (P < 0:05) (Figure 1(a) ). We further observed the protective effect of MgH 2 on LPS-induced ARDS using H&E staining, and found that lung injury was alleviated after MgH 2 administration as compared with LPS group (Figure 1(b) ). Severe lung hemorrhage, lung edema, inflammatory cell infiltration, and thickening of the alveolar septa were observed in LPS group, all of which were alleviated after MgH 2 administration. Consistently, the lung injury score was largely reduced in mice pretreated with MgH 2 (Figure 1(c) ), and the wet-todry (W/D) ratio of the lung tissues was decreased in LPS +MgH 2 group (Figure 1(d) ). Then, we used another ARDS model (LPS, 5 mg/kg, i.t.) to detect the protective effect of MgH 2. H&E staining, the lung injury score, and the W/D ratio of the lung tissues were also analyzed. As shown in Figure S1 , after LPS intratracheal injection, the images of the lung showed severe lung hemorrhage, lung edema, inflammatory cell infiltration, and thickening of the alveolar septa. The lung injury score 3 Oxidative Medicine and Cellular Longevity and W/D ratio were increased by LPS. However, the administration of MgH 2 attenuated lung injury. 5 Oxidative Medicine and Cellular Longevity by detecting the amount of intracellular ROS and used NAC as a positive control, which is known as an effective ROS remover. The results showed that the generation of ROS in the LPS-induced AEC damage model was suppressed after MgH 2 treatment via DCFH-DA staining with immunofluorescence detection, in NAC group, the expression of ROS was also decreased (Figure 2(b) ). Next, we used the mitochondrial function as the marker of oxidative stress [30] and found that MgH 2 also alleviated the ratio of JC-1 aggregates/monomers (Figures 2(c) and 2(d) ) and the expression of mitoSOX (Figures 2(e) and 2(f)) in the damage model caused by LPS in AEC as what were detected in NAC group.

Apoptosis in AEC Damage following LPS Exposure. Inflammatory cytokines (IL-1β, IL-6, and TNF-α) were detected as inflammatory response markers for the antiinflammatory effects of MgH 2 in AEC (Figures 3(a) and  3(b) ). NAC was used as a positive control and the effects of MgH 2 on the inflammatory response were similar to those of NAC. In addition, critical apoptosis-related proteins Bax, Bcl-2, and cytochrome c were detected to show the antiapoptotic effect of MgH 2 (Figure 3(c) ). Occludin and ZO-1 are known as the major components of the tight junction in the AEC surface to prevent the leakage of tissue fluid into the alveolar space [31] . It was found that MgH 2 treatment also alleviated damage to the barrier (Figure 3(d) ) in LPSinduced AEC damage.

Tissues of Endotoxemia Mice. To clarify the protective effect of MgH 2 on ARDS, MDA, SOD, and GSH levels were detected in the lung tissues. It was found that MDA in LPS group was significantly elevated and the levels of SOD and GSH showed the opposite trend. MgH 2 treatment reversed these oxidative stress markers (Figures 4(a)-4(c) ). We next detected 8-oxo-dG, the enzyme responsible for the excision of 8-oxoguanine. As expected, LPS increased 8-oxo-dG markedly, and this increasing trend was reversed after MgH 2 treatment in vivo (Figure 4(d) , Figure S2A ).

Apoptosis in Lung Tissues in Endotoxemia Mice. BALF were extracted from mice in all groups, and the levels of inflammatory cytokines in BALF were detected by ELISA in all groups. The concentrations of IL-1β, IL-6, and TNF-α in BALF ( Figure 5(a) ) and RT-qPCR analysis of IL-1β, IL-6, and TNF-α in lung tissues ( Figure 5(b) ) in LPS group were significantly higher than those in CON group, and MgH 2 Oxidative Medicine and Cellular Longevity administration effectively suppressed these inflammatory cytokines.

Lung injury is known to be associated with cell apoptosis and barrier damage. TUNEL staining was used to determine the apoptosis of cells. It was found that a great number of positive staining points were distributed in LPS group. After MgH 2 treatment, LPS-induced cell apoptosis was reduced as compared with LPS group (Figures 5(c) and 5(d) ). Apoptosis-related proteins showed the same trends in two types of ARDS models ( Figure 5 (e), Figure S2B ). Additionally, occludin and ZO-1 expressions were downregulated after LPS stimulation, and these trends were reversed after MgH 2 treatment ( Figure 5 (f), Figure S2C ). Oxidative Medicine and Cellular Longevity in vivo. NF-κB transcription factors regulate the expressions of hundreds of genes involved in regulating oxidative stress, cell apoptosis, and inflammation [32] . In addition, NF-κB is important for inflammasome priming and assembly [33] and the activation of NLRP3 plays a crucial role in the occurrence and development of ARDS [34] . To determine whether MgH 2 suppressed oxidative stress, inflammation, cell apoptosis, and barrier breakdown via AKT/mTOR pathway and NF-κB/NLRP3/IL-1β pathway, we used MgH 2 to treat LPS-induced AEC and found that p-AKT, p-mTOR, and p-P65 were up-regulated in LPS group. The activation of inflammasome was accompanied with the up-regulation of NLRP3, cleaved-caspase-1, and mature IL-1β in LPS group. Of interest, MgH 2 could significantly reduce the expressions of these proteins just as the effects of NAC (Figures 6(a) and 6(b) ). The same experiments were conducted in vivo. It was found that the expressions of p-AKT and p-mTOR were increased in LPS group, and decreased after oral MgH 2 administration. The similar trends were shown in the expressions of NLRP3, cleaved-caspase-1, and mature IL-1β (Figures 6(c) and 6(d), Figure S3A, B) . What's more, the results of immunohistochemistry showed that the expressions of NLRP3 and IL-1β were obviously elevated in the lung tissues in LPS group, and reduced in LPS +MgH 2 group (Figure 6(e) , Figure S3C ). 

ARDS is a common disease infected with Gram-negative bacteria containing LPS that affects millions of people worldwide. Inflammation, oxidative stress, and epithelial barrier impairment are the main characteristics of ARDS, leading to high mortality of ARDS patients [35] . Therefore, drugs with the effects of reducing inflammation, and oxidative stress and repairing the epithelial barrier function should be able to exert an unexpected therapeutic effect on ARDS. To the best of our knowledge, our study is the first one to investigate the effects of MgH 2 in murine and cell models of ARDS.

In this study, we firstly showed these following findings: (1) MgH 2 administration improved the survival rate of ARDS mice induced by LPS. (2) MgH 2 administration reduced lung injury scores, alleviated lung edema, inflammatory cell infiltration, thickening of the alveolar septa, and inflammatory cytokines in ARDS mice. (3) MgH 2 administration decreased oxidative stress and cell apoptosis and restored tight junctions in vitro and in vivo. (4) MgH 2 regulated AKT/mTOR pathway and NF-κB/NLRP3/IL-1β pathway in vitro and in vivo.

This study discovered that MgH 2 administration improved the survival rate of LPS-induced ARDS mice and reduced inflammation in lung tissues. As described in the introduction, MgH 2 can produce Mg(OH) 2 and H 2 follow-ing hydrolysis reaction in the stomach: MgH 2 +2H 2 O → Mg(OH) 2 +2H 2 . Mice treated with Mg(OH) 2 showed no effects when compared with MgH 2 , which means H 2 is the main cause of these changes in this study. Inflammation is a common process in many diseases, which promotes the excessive activation of the immune system and the release of several cytokines. A lot of research reported that molecular hydrogen therapy reduced the levels of inflammatory cytokines and increased anti-inflammatory cytokines [36] [37] [38] . These effects can be induced by reducing the number of inflammatory cells [14] and inhibiting the activity of ONOO- [39] .

The study also found that MgH 2 administration decreased oxidative stress in vitro and in vivo. Oxidative stress, the imbalance of oxidants and antioxidants, is the critical role in the process of ARDS. The excessive expression of oxidants such as ROS, which is generated by the electron leakage of the mitochondrial respiratory chain, causes the oxidative burst. Molecular hydrogen has been reported to alleviate oxidative stress in some ways. For one hand, hydrogen can selectively suppress •OH and ONOO-to alleviate oxidative stress [12] . For another hand, hydrogen can indirectly act on the antioxidant system to alleviate oxidative stress via enhancing antioxidant enzyme activity and antioxidant gene expression, repairing mitochondrial function [40, 41] . In this regard, our results were consistent with those of Naomi Kamimura et al. [37] , who pointed out in their 

Oxidative Medicine and Cellular Longevity research that MgH 2 reduced the expression of 4-HNE, which is regarded as a second messenger in oxidative stress signaling [42] . Furthermore, it was also revealed in our research that after MgH 2 administration, the expressions of Bax and cleaved-caspase-3 were remarkably down-regulated while Bcl-2, ZO-1, and occludin were up-regulated notably. Apoptosis is found to be triggered off by two pathways, the intrinsic pathway is related to modulators within the cell itself and the extrinsic pathway is related to extracellular stimuli and apoptosis receptors on the cell membrane [43] , the former of which is associated with cytochrome c, cleaved-caspase-3, Bax, and Bcl-2. Hydrogen was reported to protect DNA and proteins from free radicals and keep the normal mitochondrial functions to down-regulate apoptosis [44, 45] . In addition, occludin and ZO-1 are the components of the tight junctions to prevent the alveolar space from the leakage of tissue fluid [31] . As for tight junction, Yu et al. have shown that hydrogen can protect the bloodbrain barrier by decreasing its permeability via increase ZO-1 and VE-cadherin expressions [46] . Hydrogen-rich saline was also reported to maintain the integrity of intestinal epithelial tight junction barrier in rats with intestinal ischemia-reperfusion injury [47] and protect lung microvasculature of mice from sepsis-induced endothelial dysfunction and maintain the coherence of pulmonary endothelium [48] .

In the global breakout of COVID-19, ARDS is one of the characteristics of COVID-19 and lacks effective therapies [49] . In China, hydrogen-oxygen inhalation for the treatment of COVID-19 has been proposed in the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7&8)". Guan et al. [50] showed the efficacy of hydrogen/oxygen mixed gas inhalation in patients with COVID-19 in a multicenter, open-label clinical trial. Yang et al. [51] and Wang et al. [52] reviewed hydrogen therapy in treatment against COVID-19. Results in our study may provide a potential approach to combat novel coronavirus pneumonia clinically.

Taking what has been stated above into consideration, we can draw the conclusion that MgH 2 administration ameliorates endotoxin-induced acute respiratory distress syndrome by inhibiting inflammation, oxidative stress, and cell apoptosis, thus promising a new target for managing endotoxin-induced ARDS. Hydrogen has efforts against many diseases. However, there are still no effective ways to detect the diffusion of hydrogen in vitro and in vivo. Firstly, hydrogen diffuses rapidly and widely. Secondly, there are still no tracer methods to examine hydrogen distribution in the tissues and circulation. What's more, the direct targets of hydrogen remain unclear due to the rapid and extensive diffusion of hydrogen. More experimental and clinical research is required to detect the specific mechanism of hydric action in cells and mice. Therefore, more studies should be carried out and have the findings applied to benefit people with endotoxininduced ARDS.

This study demonstrated that MgH 2 alleviates ARDS in vitro and in vivo through regulating AKT/mTOR pathway and NF-κB/NLRP3/IL-1β pathway. Besides, MgH 2 plays an important role in alleviating LPS-induced ARDS by relieving lung edema and pulmonary histological damage, and suppressing the inflammatory response, oxidative stress, cell apoptosis, and barrier breakdown. All these findings suggest that MgH 2 could be an effective and promising therapeutic option for the prevention of ARDS. 

Oxidative Medicine and Cellular Longevity

We declare that the materials described in the manuscript, including all relevant raw data, will be freely available to any scientist who wishes to use them for noncommercial purposes, without breaching participant confidentiality.

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Xin Lv, Hongtao Lu, and Xuejun Sun were involved in the design and execution of experiments and manuscript revision. Xuan Shi, Sheng Wang, Juan Wei, Meiyun Liu, and Yuanli Chen were all involved in the execution of experiments. Lina Zhu and Quanfu Li were involved in data acquisition and analysis. Xuan Shi, Wanli Zhu, and Di Feng drafted the manuscript. All authors have provided final approval of the version to be submitted. Xuan Shi, Lina Zhu, and Sheng Wang contributed equally to this work. Xuan Shi, Lina Zhu, and Sheng Wang contributed equally to this work.

This study was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81671947 and 81871601 to Xin Lv), grants from Shanghai Pulmonary Hospital, 2021, Development Fund of Anesthesiology (Xin Lv), grants from Medical Science and Technology Youth Cultivation Program (21QNPY035) (Hongtao Lu), and Foundation of Center of Hydrogen Science (WF510105001) (Xuejun Sun). Figure S1 . MgH 2 attenuates LPS-induced ARDS. A. Mice were treated with LPS intratracheally (LPS, 5 mg/kg). The H&E staining of lung tissues (100x and 200x) . B. The lung injury score of mice in different groups. C. The lung W/D ratio. * P < 0:05 vs. the CON group, # P < 0:05 vs. the LPS group. Figure S2 . MgH 2 attenuates LPS-induced oxidative stress and cell apoptosis in lung tissues of endotoxemia mice. A. 8-oxo-dG immunohistochemistry staining in the lung tissues (200x). B. The levels of critical apoptosis-related proteins in the lung tissues. C. The levels of critical barrierrelated proteins in the lung tissues. Figure S3 . MgH 2 suppresses AKT/mTOR pathway and NF-κB/NLRP3/IL-1β pathway in endotoxemia mice. A and B. MgH 2 inhibits AKT/mTOR pathway and NF-κB/NLRP3/IL-1β pathway related proteins in vivo. C. NLRP3 and IL-1β immunohistochemistry staining in the lung tissues (100x). Table S1 . Primers used for reverse transcription-quantitative PCR. (Supplementary Materials) 

Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study

Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury

Acute respiratory distress syndrome

Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury

USP9X promotes LPS-induced pulmonary epithelial barrier breakdown and hyperpermeability by activating an NF-κBp65 feedback loop

Alveolar-capillary membrane-related pulmonary cells as a target in endotoxininduced acute lung injury

Acute lung injury: apoptosis and signaling mechanisms

Risk factors for physical impairment after acute lung injury in a national, multicenter study

The acute respiratory distress syndrome: pathogenesis and treatment

Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome

Activated protein C for sepsis

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals

Recent advances in hydrogen research as a therapeutic medical gas

Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury

Oral hydrogen water prevents chronic allograft nephropathy in rats

Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress

H(2) gas improves functional outcome after cardiac arrest to an extent comparable to therapeutic hypothermia in a rat model

Hydrogen inhalation during normoxic resuscitation improves neurological outcome in a rat model of cardiac arrest independently of targeted temperature management

Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury

Hydrogen-rich saline protects against renal ischemia/reperfusion injury in rats

Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo

Hydrogen gas inhalation protects against cigarette smoke-induced COPD development in mice

Hydrogen inhalation ameliorates ventilator-induced lung injury

Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats

Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes

Molecular hydrogen stimulates the gene expression of transcriptional coactivator PGC-1α to enhance fatty acid metabolism

Nrf2 activation protects against intratracheal LPS induced mouse/murine acute respiratory distress syndrome by regulating macrophage polarization

α-ketoglutarate modulates macrophage polarization through regulation of PPARγ transcription and mTORC1/p70S6K pathway to ameliorate ALI/ ARDS

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy

Role of stretch on tight junction structure in alveolar epithelial cells

The complexity of NF-κB signaling in inflammation and cancer

The inflammasomes

NLRP3 inflammasome activation by microRNA-495 promoter methylation may contribute to the progression of acute lung injury

Acute respiratory distress syndrome

Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release

Combination therapy with molecular hydrogen and hyperoxia in a murine model of polymicrobial sepsis

Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury

Antiinflammatory effect of hydrogen-rich saline in a rat model of regional myocardial ischemia and reperfusion

Molecular hydrogen: current knowledge on mechanism in alleviating free radical damage and diseases

Recent advances in studies of molecular hydrogen against sepsis

Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

Molecular hydrogen modulates gene expression via histone modification and induces the mitochondrial unfolded protein response

Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species * 210

Hydrogen gas alleviates bloodbrain barrier impairment and cognitive dysfunction of septic mice in an Nrf2-dependent pathway

Hydrogen-rich saline protects intestinal epithelial tight junction barrier in rats with intestinal ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress-induced apoptosis pathway

Hydrogen treatment prevents lipopolysaccharide-induced pulmonary endothelial cell dysfunction through RhoA inhibition

Acute respiratory distress syndrome

Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial

Hydrogen: a potential new adjuvant therapy for COVID-19 patients

Hydrogen therapy as an effective and novel adjuvant treatment against COVID-19